Department of Pathology, Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Department of Otolaryngology, Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Diagn Cytopathol. 2022 Aug;50(8):E223-E229. doi: 10.1002/dc.24971. Epub 2022 May 6.
Mesenchymal tumors harboring GLI1 gene fusions are a rare new entity that typically occur in the head and neck region of young to middle aged adults, with a particular predilection for the tongue. We report herein a case of epithelioid mesenchymal tumor with PTCH1-GLI1 gene fusion of the right submental region in an 82-year-old male never smoker. Ultrasound-guided fine needle aspiration (FNA) with concomitant core needle biopsy was performed. Cytology smears revealed a hypercellular, monotonous aspirate comprised of epithelioid to plasmacytoid cells with round regular nuclei and moderate amounts of cytoplasm. There were admixed granulomata. The patient underwent surgical resection with limited neck dissection and subsequent pathologic examination with performed next generation sequencing confirmed the presence of epithelioid mesenchymal tumor with PTCH1-GLI1 gene fusion. To our knowledge, this is the first reported example of a mesenchymal tumor harboring GLI1 gene fusion initially evaluated by FNA.
具有 GLI1 基因融合的间叶性肿瘤是一种罕见的新实体,通常发生在年轻到中年成年人的头颈部,特别是舌部。我们在此报告一例 82 岁男性,从不吸烟,右下颌下区具有 PTCH1-GLI1 基因融合的上皮样间叶性肿瘤。进行了超声引导下的细针抽吸(FNA)联合核心针活检。细胞学涂片显示增生的、单一的抽吸物,由上皮样到浆细胞样细胞组成,具有规则的圆形核和中等量的细胞质。有混合性肉芽肿。患者接受了手术切除和有限的颈部清扫,随后进行了下一代测序的病理检查,证实了存在具有 PTCH1-GLI1 基因融合的上皮样间叶性肿瘤。据我们所知,这是首例通过 FNA 评估的具有 GLI1 基因融合的间叶性肿瘤。